Literature DB >> 24569580

Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy.

Ioannis N Petropoulos1, Uazman Alam, Hassan Fadavi, Andrew Marshall, Omar Asghar, Mohammad A Dabbah, Xin Chen, James Graham, Georgios Ponirakis, Andrew J M Boulton, Mitra Tavakoli, Rayaz A Malik.   

Abstract

PURPOSE: To assess the diagnostic validity of a fully automated image analysis algorithm of in vivo confocal microscopy images in quantifying corneal subbasal nerves to diagnose diabetic neuropathy.
METHODS: One hundred eighty-six patients with type 1 and type 2 diabetes mellitus (T1/T2DM) and 55 age-matched controls underwent assessment of neuropathy and bilateral in vivo corneal confocal microscopy (IVCCM). Corneal nerve fiber density (CNFD), branch density (CNBD), and length (CNFL) were quantified with expert, manual, and fully-automated analysis. The areas under the curve (AUC), odds ratios (OR), and optimal thresholds to rule out neuropathy were estimated for both analysis methods.
RESULTS: Neuropathy was detected in 53% of patients with diabetes. A significant reduction in manual and automated CNBD (P < 0.001) and CNFD (P < 0.0001), and CNFL (P < 0.0001) occurred with increasing neuropathic severity. Manual and automated analysis methods were highly correlated for CNFD (r = 0.9, P < 0.0001), CNFL (r = 0.89, P < 0.0001), and CNBD (r = 0.75, P < 0.0001). Manual CNFD and automated CNFL were associated with the highest AUC, sensitivity/specificity and OR to rule out neuropathy.
CONCLUSIONS: Diabetic peripheral neuropathy is associated with significant corneal nerve loss detected with IVCCM. Fully automated corneal nerve quantification provides an objective and reproducible means to detect human diabetic neuropathy.

Entities:  

Keywords:  corneal confocal microscopy; diabetes; diabetic neuropathy

Mesh:

Year:  2014        PMID: 24569580      PMCID: PMC3979234          DOI: 10.1167/iovs.13-13787

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  39 in total

1.  Variables associated with corneal confocal microscopy parameters in healthy volunteers: implications for diabetic neuropathy screening.

Authors:  T Wu; A Ahmed; V Bril; A Orszag; E Ng; P Nwe; B A Perkins
Journal:  Diabet Med       Date:  2012-09       Impact factor: 4.359

2.  Repeatability of measuring corneal subbasal nerve fiber length in individuals with type 2 diabetes.

Authors:  Nathan Efron; Katie Edwards; Nicola Roper; Nicola Pritchard; Geoff P Sampson; Ayda M Shahidi; Dimitrios Vagenas; Anthony Russell; Jim Graham; Mohammad A Dabbah; Rayaz A Malik
Journal:  Eye Contact Lens       Date:  2010-09       Impact factor: 2.018

3.  Dual-model automatic detection of nerve-fibres in corneal confocal microscopy images.

Authors:  M A Dabbah; J Graham; I Petropoulos; M Tavakoli; R A Malik
Journal:  Med Image Comput Comput Assist Interv       Date:  2010

4.  Automatic recognition of corneal nerve structures in images from confocal microscopy.

Authors:  Fabio Scarpa; Enrico Grisan; Alfredo Ruggeri
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-09       Impact factor: 4.799

5.  Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study.

Authors:  Katie Edwards; Nicola Pritchard; Dimitrios Vagenas; Anthony Russell; Rayaz A Malik; Nathan Efron
Journal:  Clin Exp Optom       Date:  2012-04-29       Impact factor: 2.742

6.  Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients.

Authors:  R A Malik; P Kallinikos; C A Abbott; C H M van Schie; P Morgan; N Efron; A J M Boulton
Journal:  Diabetologia       Date:  2003-05-09       Impact factor: 10.122

7.  Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy.

Authors:  Mitra Tavakoli; Cristian Quattrini; Caroline Abbott; Panagiotis Kallinikos; Andrew Marshall; Joanne Finnigan; Philip Morgan; Nathan Efron; Andrew J M Boulton; Rayaz A Malik
Journal:  Diabetes Care       Date:  2010-04-30       Impact factor: 19.112

8.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.

Authors:  P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

9.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

Authors:  P Reichard; B Y Nilsson; U Rosenqvist
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

10.  Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy.

Authors:  Ioannis N Petropoulos; Uazman Alam; Hassan Fadavi; Omar Asghar; Patrick Green; Georgios Ponirakis; Andrew Marshall; Andrew J M Boulton; Mitra Tavakoli; Rayaz A Malik
Journal:  Diabetes Care       Date:  2013-07-22       Impact factor: 19.112

View more
  87 in total

Review 1.  Diabetic retinopathy is a neurodegenerative disorder.

Authors:  Stephanie K Lynch; Michael D Abràmoff
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

2.  Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density.

Authors:  Xin Chen; Jim Graham; Mohammad A Dabbah; Ioannis N Petropoulos; Georgios Ponirakis; Omar Asghar; Uazman Alam; Andrew Marshall; Hassan Fadavi; Maryam Ferdousi; Shazli Azmi; Mitra Tavakoli; Nathan Efron; Maria Jeziorska; Rayaz A Malik
Journal:  Diabetes Care       Date:  2015-03-20       Impact factor: 19.112

3.  Sensory nerve regeneration after epithelium wounding in normal and diabetic cornea.

Authors:  Fu-Shin Yu; Jia Yin; Patrick Lee; Frank S Hwang; Mark McDermott
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

Review 4.  In vivo corneal confocal microscopy in diabetes: Where we are and where we can get.

Authors:  Ernesto Maddaloni; Francesco Sabatino
Journal:  World J Diabetes       Date:  2016-09-15

5.  A rapid decline in corneal small fibers and occurrence of foot ulceration and Charcot foot.

Authors:  Cirous Dehghani; Anthony W Russell; Bruce A Perkins; Rayaz A Malik; Nicola Pritchard; Katie Edwards; Ayda M Shahidi; Sangeetha Srinivasan; Nathan Efron
Journal:  J Diabetes Complications       Date:  2016-07-16       Impact factor: 2.852

6.  Comparative quantitative assessment of the human corneal sub-basal nerve plexus by in vivo confocal microscopy and histological staining.

Authors:  B S Kowtharapu; K Winter; C Marfurt; S Allgeier; B Köhler; M Hovakimyan; T Stahnke; A Wree; O Stachs; R F Guthoff
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

Review 7.  In Vivo Confocal Microscopy of Corneal Nerves in Health and Disease.

Authors:  Andrea Cruzat; Yureeda Qazi; Pedram Hamrah
Journal:  Ocul Surf       Date:  2016-10-19       Impact factor: 5.033

8.  ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.

Authors:  Michael Brines; Ann N Dunne; Monique van Velzen; Paolo L Proto; Claes-Goran Ostenson; Rita I Kirk; Ioannis N Petropoulos; Saad Javed; Rayaz A Malik; Anthony Cerami; Albert Dahan
Journal:  Mol Med       Date:  2015-03-13       Impact factor: 6.354

9.  Combining efficient hand-crafted features with learned filters for fast and accurate corneal nerve fibre centreline detection.

Authors:  Roberto Annunziata; Ahmad Kheirkhah; Pedram Hamrah; Emanuele Trucco
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2015-08

10.  An Automatic Tool for Quantification of Nerve Fibers in Corneal Confocal Microscopy Images.

Authors:  Xin Chen; Jim Graham; Mohammad A Dabbah; Ioannis N Petropoulos; Mitra Tavakoli; Rayaz A Malik
Journal:  IEEE Trans Biomed Eng       Date:  2016-06-07       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.